Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion.
Miami Cancer Institute can provide access to clinical trials not widely available elsewhere. Clinical trials find new ways to treat and diagnose cancer and are ongoing. If an appropriate trial is available, we will talk to you about the benefits and risks.
Peter J. DeMaria, M.D., is a board-certified medical oncologist at Baptist Health and speaks fluent English and Spanish.
At Baptist Health Miami Cancer Institute, Dr. DeMaria is responsible for developing and overseeing a portfolio of clinical studies of novel cancer therapies that are in the early stages of development.
As a Miami native, he is excited to be part of a program at Baptist Health that provides additional local options for cancer patients in South Florida who have exhausted standard-of-care treatment and want to participate in clinical trials of investigational cancer therapies.
Dr. DeMaria believes that while clinical trials are designed to answer important questions in the development of new cancer therapies, they provide hope to patients with limited available treatment options. As a cancer physician, he values the vital role he is afforded as a communicator, educator and guide during a difficult and challenging time in the lives of his patients and their families.
In his free time, Dr. DeMaria enjoys outdoor activities such as biking, boating, skiing and traveling to experience new places and people.
As Florida's only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management team match those at MSK.
Miami Cancer Institute was recognized as a top 3 Best Cancer Hospital in the South Florida region by U.S. News & World Report.